Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...
Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, expectations were $1.74. Operator: Hello, and welcome to the Second Quarter ...
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.
Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep ...
Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its Pharmaceuticals segment.
Valiquette also increased his earnings per share (EPS) estimates for Cardinal Health (NYSE:CAH), raising the fiscal year 2025 forecast from $7.90 to $7.95 and the fiscal year 2026 projection from $8 ...
With these words the newly created Philippine Cardinal Pablo Virgilio David y Siongco addressed Pope Francis after finding out that his name appeared among the new cardinals on the list for the ...
Cardinal Christoph Schönborn, OP, concluded his term as archbishop of Vienna, Austria, on Wednesday, his 80th birthday, when Pope Francis accepted his resignation. Schönborn, a theologian who ...
Canadians Cardinal Michael Czerny and sculptor Timothy P. Schmalz on Thursday in Rome spoke about evangelization through art as part of festivities linked to the Jan. 24–26 Jubilee of the World ...
He told the BBC the new complex would be delivered for patients of Cardinal Medical Practice. "You're thinking along the right lines," he said, when pressed on whether the NHS would buy and ...